Login / Signup

Efficient simulation of clinical target response surfaces.

Daniel LillAnne KümmelVenelin MitovDaniel KaschekNathalie GobeauHenning SchmidtJens Timmer
Published in: CPT: pharmacometrics & systems pharmacology (2022)
Simulation of combination therapies is challenging due to computational complexity. Either a simple model is used to simulate the response for many combinations of concentration to generate a response surface but parameter variability and uncertainty are neglected and the concentrations are constant-the link to the doses to be administered is difficult to make-or a population pharmacokinetic/pharmacodynamic model is used to predict the response to combination therapy in a clinical trial taking into account the time-varying concentration profile, interindividual variability (IIV), and parameter uncertainty but simulations are limited to only a few selected doses. We devised new algorithms to efficiently search for the combination doses that achieve a predefined efficacy target while taking into account the IIV and parameter uncertainty. The result of this method is a response surface of confidence levels, indicating for all dose combinations the likelihood of reaching the specified efficacy target. We highlight the importance to simulate across a population rather than focus on an individual. Finally, we provide examples of potential applications, such as informing experimental design.
Keyphrases
  • combination therapy
  • clinical trial
  • machine learning
  • randomized controlled trial
  • deep learning
  • risk assessment
  • staphylococcus aureus
  • candida albicans